Study: OTC ibuprofen as effective as Rx in treating post-operative pain after having tonsils removed
DETROIT — A patient may be able to eat all of the ice cream he wants after having his tonsils removed, but researchers at Henry Ford Hospital in Detroit say he doesn’t necessarily need a prescription to reduce post-operative pain — an over-the-counter pain reliever is just as effective.
The study released Monday found over-the-counter ibuprofen manages pain after a tonsillectomy for children and adults, as well as the prescription pain medications acetaminophen with hydrocodone and acetaminophen with codeine, which is no longer recommended for use in children.
“Based on this study and the FDA warning about the risks of children taking any medication with codeine, we recommend that children receive over-the-counter ibuprofen after a tonsillectomy,” stated lead study author Robert Standring with the Department of Otolaryngology-Head and Neck Surgery at Henry Ford. “Ibuprofen appears to be the safest alternative that still provides adequate pain control for children.”
Study results were presented Oct. 1 at the 2013 American Academy of Otolaryngology-Head and Neck Surgery (AAO-HNS) annual meeting in Vancouver, British Columbia.
GNC acquires U.K. sports nutrition e-commerce retailer
PITTSBURGH — GNC Holdings on Wednesday announced it has acquired A1 Sports Limited (d.b.a. Discount Supplements), a multi-brand sports nutrition e-commerce retailer in the United Kingdom.
The acquisition was funded with cash on hand. Terms of the deal were not disclosed.
Following the acquisition, GNC.com, LuckyVitamin.com and discount-supplements.co.uk will continue to operate as separate businesses, each with its own product offerings and target customers.
"Discount Supplements offers a broad selection of competitively priced proprietary and third-party products, and is a leader in the U.K.’s sports nutrition market," stated Joe Fortunato, GNC chairman, president and CEO. "This market — estimated to be [$485.9 million] — has demonstrated consistent double-digit growth, which is forecasted to continue. The online channel has captured nearly one-third market share and is growing faster than the market overall," he said.
"Entering the U.K. and other key European and Scandinavian markets are core elements of our strategic plan to expand GNC’s global reach," Fortunato added. "With this acquisition, we are well positioned to capitalize on the fastest-growing channel in Europe’s top market. We also see the potential to leverage GNC’s marketing, product development and procurement capabilities to drive synergies. This includes having Discount Supplements introduce premium GNC sub-brands in the sports nutrition, vitamin and diet categories into the U.K. and other markets."
Discount Supplements — founded in 2004 — is expected to grow to approximately $32.4 million million in revenue in 2013.
Research Now launches diabetes panel
PLANO, Texas — Research Now announced the launch of its Diabetes Panel, a collection of 336,000 deeply-profiled panelists in the United States and Canada who have been diagnosed with Type 1 diabetes, Type 2 diabetes, high blood pressure or obesity. Research Now’s Healthcare Panels also include physicians, nurses, pharmacists, hospital executives and administrators.
"As the nature and treatment of health conditions is so complex, we wanted to enforce the need to get insights from a variety of healthcare professionals and caregivers that go beyond a standard doctor," stated Vincent DeRobertis, SVP global healthcare for Research Now. "Due to high client demand, our Diabetes Panel is the first in a series of condition-based panels that we will be rolling out over the next 12 months. Our goal for this series is to be able to approach each condition uniquely, and focus on holistic solutions that will provide a deeper knowledge base of the condition."
Of the original 2,000 respondents who were pre-screened, approximately three-quarters of both Americans and Canadians reported that they, or someone they know, have diabetes. Among the 75% of respondents in the United States, 17% reported having Type 1 (2.3%) or Type 2 (14.7%) diabetes, whereas only 8.8% of this surveyed audience in Canada reported having Type 1 (2.3%) or Type 2 (6.5%) diabetes.
In order to prevent diabetes, 69% of the surveyed audience in both the United States and Canada who did not report having diabetes said they watch their sugar intake and try to maintain a proper diet and workout regimen.
"What’s most disturbing about this study is that, despite diabetes being one of the fastest growing diseases in America, both Americans and Canadians struggle with recognizing the symptoms," DeRobertis noted. Among the surveyed audience in the United States, 61% of respondents acknowledged they were aware of some of the symptoms of Type 1 diabetes. However, of this group, only 35% could accurately name a symptom. Among the same audience, 69% acknowledged they were aware of some of the symptoms of Type 2 diabetes, but just 43% could accurately name a symptom.
Likewise, 57% of the surveyed Canadian audience acknowledged they were aware of some of the symptoms of Type 1 diabetes, but only 32% could accurately name a symptom. And among the same audience, 63% acknowledged they were aware of some of the symptoms of Type 2 diabetes, but just 38% could accurately name a symptom.
The survey went on to find that just 64% of U.S. respondents and 54% of Canadian respondents agree that their healthcare provider supplies adequate information about diabetes awareness and prevention.
"It is impactful stats like these that help to illustrate the lack of awareness when it comes to diabetes, and where healthcare providers should take more notice," DeRobertis said. "As we move into a new era of Obamacare and next-generation medical technologies, it is imperative that more resources be directed toward diabetes management tools and health programs to prevent diabetes."